Dr. Md. David A. Reardon Center for Neuro-Oncology Dana-Farber Cancer Institute, USA

David Reardon is the Clinical Director of the Center for Neuro-oncology at Dana Faber Medical Institute and Professor of Medicine at Harvard Medical School. His career objective has been to improve outcome for brain tumor patients. He joined an outstanding team led by long-term friend and collaborator, Patrick Wen that... read morehas fostered several exciting endeavors. First, he is leading preclinical studies evaluating immune based therapies using an orthotopic, immunocompetent glioblastoma model, in collaboration with outstanding colleagues from the DFCI cancer immunology group including Gordon Freeman and Glenn Dranoff. Results of this work have supported development of several clinical trials which are anticipated to initiate soon. Second, he has helped to significantly expand the clinical research portfolio of the Center. He currently serves as principal investigator for 6 clinical trials that opened in the past year. He has published extensively in peer-reviewed journals, presented at numerous national and international conferences, conducted training for neuro-oncology fellows and in 2013 was elected President of the Society for Neuro-oncology, the major society in the field.